Literature DB >> 12198537

Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.

Harith Rajagopalan1, Alberto Bardelli, Christoph Lengauer, Kenneth W Kinzler, Bert Vogelstein, Victor E Velculescu.   

Abstract

Genes of the RAF family encode kinases that are regulated by Ras and mediate cellular responses to growth signals. Activating mutations in one RAF gene, BRAF, have been found in a high proportion of melanomas and in a small fraction of other cancers. Here we show that BRAF mutations in colorectal cancers occur only in tumours that do not carry mutations in a RAS gene known as KRAS, and that BRAF mutation is linked to the proficiency of these tumours in repairing mismatched bases in DNA. Our results not only provide genetic support for the idea that mutations in BRAF and KRAS exert equivalent effects in tumorigenesis, but also emphasize the role of repair processes in establishing the mutation spectra that underpin human cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198537     DOI: 10.1038/418934a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  405 in total

Review 1.  Colorectal cancer: chemopreventive role of curcumin and resveratrol.

Authors:  Vaishali B Patel; Sabeena Misra; Bhaumik B Patel; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer.

Authors:  María Dolores Giráldez; Francesc Balaguer; Luis Bujanda; Miriam Cuatrecasas; Jenifer Muñoz; Virginia Alonso-Espinaco; Mikel Larzabal; Anna Petit; Victoria Gonzalo; Teresa Ocaña; Leticia Moreira; José María Enríquez-Navascués; C Richard Boland; Ajay Goel; Antoni Castells; Sergi Castellví-Bel
Journal:  Clin Cancer Res       Date:  2010-10-05       Impact factor: 12.531

Review 3.  Colorectal cancer molecular biology moves into clinical practice.

Authors:  Colin C Pritchard; William M Grady
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

4.  B-Raf mutations, microsatellite instability and p53 protein expression in sporadic basal cell carcinomas.

Authors:  Angeliki Stamatelli; Angelica A Saetta; Thaleia Bei; Nicolaos Kavantzas; Nicolaos V Michalopoulos; Efstratios Patsouris; Kiriaki Aroni
Journal:  Pathol Oncol Res       Date:  2011-01-28       Impact factor: 3.201

5.  BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas.

Authors:  Paula Soares; Vítor Trovisco; Ana Sofia Rocha; Tália Feijão; Ana Paula Rebocho; Elsa Fonseca; Inês Vieira de Castro; José Cameselle-Teijeiro; Manuel Cardoso-Oliveira; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2004-04-17       Impact factor: 4.064

6.  Dissecting cancer heterogeneity.

Authors:  David Dornan; Jeff Settleman
Journal:  Nat Biotechnol       Date:  2011-12-08       Impact factor: 54.908

Review 7.  Lynch syndrome diagnostics: decision-making process for germ-line testing.

Authors:  E Lastra; M García-González; B Llorente; C Bernuy; M J Barrio; L Pérez-Cabornero; M Durán; C García-Girón
Journal:  Clin Transl Oncol       Date:  2012-04       Impact factor: 3.405

8.  Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.

Authors:  Maria Caruso; James Moore; Gregory J Goodall; Michelle Thomas; Stuart Phillis; Anna Tyskin; Glenice Cheetham; Nancy Lerda; Hiroyuki Takahashi; Andrew Ruszkiewicz
Journal:  Virchows Arch       Date:  2009-01-27       Impact factor: 4.064

9.  Molecular Genetics of Colorectal Cancer: An Overview.

Authors:  Irfan M Hisamuddin; Vincent W Yang
Journal:  Curr Colorectal Cancer Rep       Date:  2006-04

10.  Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers.

Authors:  Il-Jin Kim; Jae-Hyun Park; Hio Chung Kang; Yong Shin; Hye-Won Park; Hye-Rin Park; Ja-Lok Ku; Seok-Byung Lim; Jae-Gahb Park
Journal:  Hum Genet       Date:  2003-09-25       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.